Top Markets
#1 Siren Siren +34.00%
#2 OriginTrail OriginTrail +29.98%
#3 Waves Waves +14.16%
#4 BasedHype BasedHype +7.63%
#5 Pons Pons +7.39%
#6 MarsCoin MarsCoin +7.06%
#7 Arcium Arcium +6.31%
#8 Cysic Cysic +6.31%
#9 TROLL TROLL +6.06%
#10 PulseChain PulseChain +5.89%
Coin of the day
Siren Siren
Settings
Language
ENGLISH
Currency
USD
Theme
Intech Biopharm Corporation Intech Biopharm Corporation

Intech Biopharm Corporation

6461
Rank in Stocks #22451
Intech Biopharm Corporation is a pharmaceutical company dedicated to the global... Intech Biopharm Corporation is a pharmaceutical company dedicated to the global development and production of generic medications for respiratory conditions. Their portfolio includes innovative drug delivery systems, such as iLEF (inhaled low ethanol formulation), a proprietary metered dose inhaler platform specifically engineered for the treatment of asthma and chronic obstructive pulmonary disease (COPD). Additionally, they offer a dry powder inhaler (DPI) technology, which utilizes blisters and capsules for precise dosage. These therapeutic solutions are marketed under various brand names, including SYN006, SYN010, SYN007, Synflutide, Duasma, Synvent, and SYN011. Established in Taipei, Taiwan, in 2010, the company maintains its headquarters in the city.
Share Price
$0.49606484
Last synced: 2026-08-21
Market Cap
$88.47M
Change (1 day)
-1.58%
Change (1 year)
-22.51%
Country
TW
Trade Intech Biopharm Corporation (6461)

Category

Healthcare
Revenue for Intech Biopharm Corporation (6461)
Revenue in Aug 2026 TTM: 0
According to Intech Biopharm Corporation latest financial reports the company's current revenue (TTM) is 0. In 2026 the company made a revenue of 0 equal to the revenue in the year 2026 that was 0. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for Intech Biopharm Corporation from 2026 to 2026
Revenue at the end of each year
Year Revenue Change
Not enough data for the provided dates.
Revenue for similar companies or competitors
Company Revenue Revenue Difference Country
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $12.62B -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $6.02B -
NL
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 $2.23B -
US
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $15.74B -
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH